Renal replacement therapy is an independent risk factor for mortality in critically ill patients with acute kidney injury
Critical Care2010Vol. 14(6), pp. R221–R221
Citations Over TimeTop 10% of 2010 papers
Monique Elseviers, R. Lins, Patricia Van der Niepen, Eric A. J. Hoste, Manu L. N. G. Malbrain, Pierre Damas, Jacques Devriendt, the SHARF investigators
Abstract
The SHARF study showed that the higher mortality expected in AKI patients receiving RRT versus conservative treatment can not only be explained by a higher disease severity in the RRT group, even after multiple corrections. A more critical approach to the need for RRT in AKI patients seems to be warranted.
Related Papers
- → Recovery of renal function after acute kidney injury requiring continuous renal replacement therapy(2014)6 cited
- → Continous renal replacement therapy and intermittent hemodialysis in acute kidney injury: equivalent or complementary?(2016)4 cited
- → 3. Renal Replacement Therapy for Acute Kidney Injury(2014)3 cited
- → Renal Replacement Therapy in Acute Kidney Injury: Indication, Proper Initiation, and Prescription(2012)
- → The effect of renal replacement therapy timing on the outcome of acute kidney injury in critically ill patients(2019)